title: Discrete virus infection model of hepatitis B virus.
abstract: In 1996 Nowak and his colleagues proposed a differential equation virus infection model, which has been widely applied in the study for the dynamics of hepatitis B virus (HBV) infection. Biological dynamics may be described more practically by discrete events rather than continuous ones. Using discrete systems to describe biological dynamics should be reasonable. Based on one revised Nowak et al's virus infection model, this study introduces a discrete virus infection model (DVIM). Two equilibriums of this model, E1 and E2, represents infection free and infection persistent, respectively. Similar to the case of the basic virus infection model, this study deduces a basic virus reproductive number R0 independing on the number of total cells of an infected target organ. A proposed theorem proves that if the basic virus reproductive number R0<1 then the virus free equilibrium E1 is locally stable. The DVIM is more reasonable than an abstract discrete susceptible-infected-recovered model (SIRS) whose basic virus reproductive number R0 is relevant to the number of total cells of the infected target organ. As an application, this study models the clinic HBV DNA data of a patient who was accepted via anti-HBV infection therapy with drug lamivudine. The results show that the numerical simulation is good in agreement with the clinic data.
authors.affiliation: School of Mathematics and Physics, University of Science and Technology Beijing, Beijing, 100083, PR China.
authors.forename: Pengfei
authors.initials: P
authors.lastname: Zhang
authors.affiliation: School of Mathematics and Physics, University of Science and Technology Beijing, Beijing, 100083, PR China.
authors.forename: Lequan
authors.initials: L
authors.lastname: Min
authors.affiliation: School of Mathematics and Physics, University of Science and Technology Beijing, Beijing, 100083, PR China.
authors.forename: Jianwei
authors.initials: J
authors.lastname: Pian
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003198:Computer Simulation; D006509:Hepatitis B / Q000188:drug therapy* / Q000503:physiopathology*; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008954:Models, Biological; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D019259:Lamivudine
keywords: Hepatitis B virus; discrete virus infection model; equilibrium stability; modeling; numerical simulation